Alkem Laboratories (ALKEM) Share Price hits fresh 52-week low at Rs 4,900
- September 11, 2026
- Posted by: Kunal Singla
- Category: News
Alkem Laboratories Share Price is in focus after the stock touched a fresh 52-week low of Rs 4,900 and was trading at Rs 4,997, up 0.04% from the previous close of Rs 4,995. The company’s market capitalisation stood at Rs 59,722.72 crore as of 21 October 2026 at 3:22 PM IST. The price move is confirmed in Univest data; a company-specific reason has not been established. For Alkem Laboratories Share Price today, the move matters because it places the stock at a yearly low while the share price remains close to its intraday range. In this Alkem Laboratories Share Price update, the latest Univest figures show a market that is tracking the stock’s price action, valuation and healthcare-sector context rather than a single stated trigger. Alkem Laboratories Share News is therefore being read through the lens of price, ratios and sector benchmarking.
Alkem Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 4,997 |
| Previous Close | Rs 4,995 |
| Today's Move | +Rs 2 (+0.04%) |
| Open | Rs 4,964.05 |
| High | Rs 5,051.95 |
| Low | Rs 4,900 |
| Market Capitalisation | Rs 59,722.72 crore |
Alkem Laboratories Ltd. (ALKEM) traded at Rs 4,997 versus the previous close of Rs 4,995, a rise of 0.04%. The stock opened at Rs 4,964.05, reached a high of Rs 5,051.95, touched a low of Rs 4,900.
Alkem Laboratories Share Price opened at Rs 4,964.05, touched a high of Rs 5,051.95 and a low of Rs 4,900, which is also the fresh 52-week low. The stock moved Rs 2 higher than the previous close and traded within a narrow band around the lower end of the day’s range. Alkem Laboratories Share Price today is therefore defined by the test of Rs 4,900, not by a wider trend statement. The company’s market capitalisation remained Rs 59,722.72 crore, keeping Alkem Laboratories Share Price in the upper tier of the listed healthcare universe. According to latest Univest data, the move confirms a one-year low event while the current price still sits above the fresh trough. For readers tracking Alkem Laboratories Share Price live, the key fact is simple: price action has reached a fresh 52-week low and the stock is now trading slightly above it. That sets up the fundamental analysis that follows.
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 59,722.72 crore |
| P/E Ratio | 27.68x |
| P/B Ratio | 4.17x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.06% |
Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 27.68x, P/B 4.17x, ROE 18.29%, ROCE 21.28%. These ratios show where the company stands today and are not a call to buy or sell.
Alkem Laboratories Ltd. has a market capitalisation of Rs 59,722.72 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 27.68x, P/B at 4.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 180.45, book value per share of Rs 1,196.51, dividend yield of 1.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.89x, median ROE of 11.23%, median ROCE of 13.24%. Together they describe the fundamental backdrop without implying a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 27.68x |
| Benchmark Median P/E | 31.89x |
| Benchmark Average P/E | 46.09x |
| Benchmark P/E Range | 3.1x to 616.89x |
| Company P/B Ratio | 4.17x |
| Benchmark Median P/B | 2.76x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.24% |
| Company Market Capitalisation | Rs 59,722.72 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Alkem Laboratories Ltd. (ALKEM) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 27.68x, which is below the benchmark median of 31.89x, a difference of -13.2%. A P/E difference of this kind is a reference point rather than a recommendation.
Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.23%, a difference of +62.87%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.24%, a difference of +60.73%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 62,339.2 | 34.67 | 5.69 | 14.1 | 20.35 |
| Biocon Ltd. | BIOCON | 55,491.09 | 112.04 | 1.63 | 1.35 | 3.26 |
| Abbott India Ltd. | ABBOTINDIA | 54,909.79 | 34.01 | 10.61 | 34.67 | 46.72 |
| Gland Pharma Ltd. | GLAND | 49,952.91 | 44.25 | 4.7 | 10.56 | 14.96 |
| Ipca Laboratories Ltd. | IPCALAB | 46,049.85 | 35.16 | 5.43 | 15.88 | 19.41 |
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 27.68x compared with the displayed peer median of 35.16x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 14.1% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.41%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 59,722.72 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price touched a fresh 52-week low of Rs 4,900 and was trading at Rs 4,997 during the day.
- The stock’s P/E of 27.68 is below the same-industry median of 31.89, while ROE and ROCE remain above the benchmark medians.
- Alkem Laboratories Share Price today is being watched alongside Rs 59,722.72 crore in market capitalisation and Jun 2026 revenue of Rs 3,740.15 crore.
- In Healthcare, the company sits within a large Pharmaceuticals & Drugs benchmark of 198 companies.
- Alkem Laboratories Stock News is now being weighed against peer valuations and return ratios rather than any stated catalyst.
About Alkem Laboratories
Alkem Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. Alkem Laboratories Share Price reflects the market’s view of a company with a broad healthcare footprint, a market cap of Rs 59,722.72 crore and a reported revenue base of Rs 3,740.15 crore in Jun 2026. As a pharmaceutical company, it earns through drug and healthcare product sales across its business operations. Alkem Laboratories Share Price is therefore tied to a business model that depends on product demand, operating execution and the market’s assessment of earnings quality. The available financial ratios show P/E, P/B, ROE, ROCE, EPS, book value and dividend yield, which together help frame the company’s position in the listed healthcare universe. For readers following Alkem Laboratories Share Price, the company stands as a sizable pharma name with measurable profitability and benchmark visibility inside Indian stock market healthcare coverage.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Track Alkem Laboratories Share Price on Univest for live price updates, valuation ratios, 52-week levels, market cap, company news and sector context. Univest also helps readers follow Alkem Laboratories Share Price today alongside fundamental ratios and peer benchmarks in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Alkem Laboratories Share Price hit a fresh 52-week low?
Ans. According to Univest data, the stock touched Rs 4,900, which is its fresh 52-week low. The figures confirm the event, but no company-specific catalyst is established, so the move is being read through price action and valuation.
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price was Rs 4,997, up Rs 2 or 0.04% from the previous close of Rs 4,995. The stock moved between Rs 4,900 and Rs 5,051.95 during the day.
What is the fresh 52-week low for Alkem Laboratories?
Ans. The fresh 52-week low for Alkem Laboratories Share Price is Rs 4,900. That level also matched the day’s low, making it the central price point in today’s share price move.
How large is Alkem Laboratories by market capitalisation?
Ans. Alkem Laboratories Share Price is backed by a market capitalisation of Rs 59,722.72 crore. That places it well above the same-industry median market cap of Rs 768.75 crore within the benchmark set.
What does Alkem Laboratories Fundamental Analysis show?
Ans. Alkem Laboratories Fundamental Analysis shows a P/E of 27.68, P/B of 4.17, ROE of 18.29%, ROCE of 21.28%, EPS of Rs 180.45 and book value of Rs 1,196.51 per share.
How does Alkem Laboratories compare with healthcare peers?
Ans. Alkem Laboratories Share Price compares with peers such as Glenmark, Biocon, Abbott India, Gland Pharma and Ipca Laboratories. Its P/E is lower than several of them, while its ROE and ROCE remain competitive in the group.
What is the sector context for Alkem Laboratories Share Price?
Ans. In the same-industry benchmark of 198 companies, Alkem Laboratories Share Price has a P/E below the median and ROE and ROCE above the median. That gives the stock a notable valuation and return profile inside Healthcare.
Where can investors track Alkem Laboratories Share Price live?
Ans. Investors can track Alkem Laboratories Share Price on Univest for live updates, 52-week levels, valuation ratios, market cap and company news. It brings together price action, fundamentals and sector context in one view.
